The relevance of these FTD panels is additionally supported by the association of some markers (e.g., MMP10, PLTP, PRDX1, and NPDC1) with clinical parameters such as cognitive functioning or disease severity. This evidence concerns the gene NPDC1 and frontotemporal dementia.